42533-0 |
Saccharomonospora viridis Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Saccharomonospora viridis Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42533-0 |
|
|
|
|
Both |
|
|
|
0 |
S viridis Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Farmers lung; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S varidis; S viridis; Sacch; Saccharomona viridis; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T virides; T viridis; Thermoactinomyces viridis |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42534-8 |
Thermoactinomyces vulgaris Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Thermoactinomyces vulgaris Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42534-8 |
|
|
|
|
Both |
|
|
|
0 |
T vulgaris Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Farmers lung; ID; Infectious Disease; InfectiousDisease; m23; m51; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rm213; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; T vulgaris; Thermoactnom |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42535-5 |
Tipranavir |
Susc |
Isolate |
Pt |
OrdQn |
|
|
ACTIVE |
Tipranavir [Susceptibility] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ABXBACT |
|
42535-5 |
|
|
|
|
Observation |
|
|
|
0 |
Tipranavir Susc Islt |
|
|
|
N |
|
ANTIBIOTIC SUSCEPTIBILITIES; Aptivus; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TPV |
2.19 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42536-3 |
Tropheryma whipplei DNA |
PrThr |
CSF |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Tropheryma whipplei DNA [Presence] in Cerebral spinal fluid by NAA with probe detection |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42536-3 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
T whipplei DNA CSF Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; T whippelii; T whippelli; T whipplei; TMA; Transcription mediated amplification; Tropheryma whippelli; Whipple's disease |
2.7 |
2.16 |
|
|
|
|
|
|
|
|
|
|
Release 2.70: COMPONENT: Corrected spelling of species name from "whippelii"; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42537-1 |
Varicella zoster virus Ab.IgG |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Varicella zoster virus IgG Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
42537-1 |
|
|
|
|
Both |
|
|
|
0 |
VZV IgG CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; VZ; VZV; Zoster |
2.56 |
2.16 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
42538-9 |
Hydroxyperhexiline |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Hydroxyperhexiline [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ug/L |
25 ug/L |
|
|
|
|
|
DRUG/TOX |
|
42538-9 |
|
|
|
|
Both |
|
|
|
0 |
OH-Phex SerPl-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Hydroxy perhexiline; Level; Mass concentration; OH-Phex; Perhexiline metabolite; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.16 |
|
|
|
|
|
|
|
ug/L |
|
|
|
0 |
42539-7 |
Hydroxyperhexiline/Perhexiline |
MRto |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Hydroxyperhexiline/Perhexiline [Mass Ratio] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
Hydroxyperhexiline/Perhexiline = 1.00 |
|
|
|
|
|
DRUG/TOX |
|
42539-7 |
|
|
|
|
Both |
|
|
|
0 |
OH-Phex/Phex SerPl |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Hydroxy perhexiline; Mass concentration ratio; Mass ratio; MCRto; OH-Phex; Perhexiline maleate; Perhexiline metabolite; Persig; PEXID; Phex; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4254-9 |
Fenproporex |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
Fenproporex [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4254-9 |
|
|
|
|
Observation |
|
|
|
0 |
Fenproporex Dose |
|
|
|
Y |
|
Addiction; Antiobes; Dicel; Dose med or substance; DRUG DOSES; Drugs of abuse; Illicit; n-2-cyanoethylamphetamine; Perphoxene; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tegisec |
2.69 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
42540-5 |
Contributing factor.environment |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Contributing Factor environment MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42540-5 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Contrib Fact environment MERSTH |
|
|
|
N |
|
Contrib Fact environment; Fac; Fact; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42541-3 |
Contributing factor.patient-related |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Contributing Factor patient-related MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42541-3 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Contrib Fact patient-related MERSTH |
|
|
|
N |
|
Contrib Fact patient-related; Fac; Fact; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42542-1 |
Contributing factor.staff-related |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Contributing Factor staff-related MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42542-1 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Contrib Fact staff-related MERSTH |
|
|
|
N |
|
Contrib Fact staff-related; Fac; Fact; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42543-9 |
Contributing factor.delay &or premature |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Contributing Factor delay/Premature MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42543-9 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Contrib Fact delay/premature MERSTH |
|
|
|
N |
|
Contrib Fact delay/premature; Fac; Fact; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42544-7 |
Contributing factor.other |
Find |
^Patient |
Pt |
Nar |
Observed.MERSTH |
|
ACTIVE |
Contributing Factor other Narrative MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42544-7 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Contrib Fact other MERSTH |
|
|
|
N |
|
Contrib Fact other; Fac; Fact; Finding; Findings; Medical Event Reporting System-Total Health System; Narrative; Othr; Patient safety; Point in time; Random; Report |
2.4 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42545-4 |
Event outcome |
Find |
^Patient |
Pt |
Ord |
Observed.MERSTH |
|
ACTIVE |
Event outcome MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42545-4 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Outcome MERSTH |
|
|
|
N |
|
Finding; Findings; Medical Event Reporting System-Total Health System; Ordinal; Patient safety; Point in time; QL; Qual; Qualitative; Random; Screen |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42546-2 |
Event battery.MERS-TH |
Find |
^Patient |
Pt |
- |
Observed.MERSTH |
|
ACTIVE |
Event battery.MERS-TH MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.PATIENT SAFETY |
|
42546-2 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Battery.MERS-TH MERSTH |
|
|
|
N |
|
Finding; Findings; Medical Event Reporting System-Total Health System; Pan; Panel; Panel.patientsafety; Panl; Patient safety; Pnl; Point in time; Random; Thallium |
2.27 |
2.16 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
42547-0 |
Event |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42547-0 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event MERSTH |
|
|
|
N |
|
Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42548-8 |
Service |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Service MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42548-8 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Service MERSTH |
|
|
|
N |
|
Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42549-6 |
Event type |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event type MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42549-6 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Type MERSTH |
|
|
|
N |
|
Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
4255-6 |
fentaNYL |
Mass |
Dose |
Pt |
Qn |
|
|
ACTIVE |
fentaNYL [Mass] of Dose |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUGDOSE |
|
4255-6 |
|
|
|
|
Observation |
|
|
|
0 |
fentaNYL Dose |
|
|
|
Y |
|
Actiq; Addiction; Dose med or substance; DRUG DOSES; Drugs of abuse; Duragesic; Durogesic; Fenpat; fentanil; Illicit; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Sublimaze |
2.73 |
1 |
|
|
|
|
|
|
|
mg |
|
|
|
0 |
42550-4 |
Event description.medication |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event description medication MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42550-4 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Desc med MERSTH |
|
|
|
N |
|
Event Desc med; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42551-2 |
Event description.procedure &or treatment &or surgery |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event description procedure/treatment/surgery MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42551-2 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Desc proc/Tx/surgery MERSTH |
|
|
|
N |
|
Event Desc proc/Tx/surgery; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random; Surg; Tx |
2.73 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42552-0 |
Event description.food &or nutrition |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event description food/nutrition MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42552-0 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Desc food/nutrition MERSTH |
|
|
|
N |
|
Event Desc food/nutrition; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42553-8 |
Event description.fall |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event description fall MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42553-8 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Desc fall MERSTH |
|
|
|
N |
|
Event Desc fall; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42554-6 |
Event description.accident |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event description accident MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42554-6 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Desc accident MERSTH |
|
|
|
N |
|
Event Desc accident; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |
42555-3 |
Event description.general nursing care |
Find |
^Patient |
Pt |
Nom |
Observed.MERSTH |
|
ACTIVE |
Event Description general nursing care MERSTH |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PATIENT SAFETY |
|
42555-3 |
|
Observed.MERSTH |
|
|
|
|
|
|
0 |
Event Desc general nursing care MERSTH |
|
|
|
N |
|
Event Desc general nursing care; Finding; Findings; Medical Event Reporting System-Total Health System; Nominal; Patient safety; Point in time; Random |
2.27 |
2.16 |
|
|
|
|
|
|
|
|
|
|
|
0 |